Showing results (11-20 of 79) with videos related to
Sort By:
Pageof 8
Neuroscience|February 10, 2007
Expression of Tgfalpha in the suprachiasmatic nuclei of nocturnal and diurnal rodentsB B Tournier, H Dardente, P Vuillez, et al.Scientific Reports|October 1, 2021
Dopaminergic dysfunction in the 3xTg-AD mice model of Alzheimer's diseaseYesica Gloria, Kelly Ceyzériat, Stergios Tsartsalis, et al.Neuropsychiatric Disease and Treatment|November 25, 2021
Dopamine and Neuroinflammation in Schizophrenia - Interpreting the Findings from Translocator Protein (18kDa) PET ImagingSotiria Maria Iliopoulou, Stergios Tsartsalis, Stefan Kaiser, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 14, 2012
Chronic Δ⁹-tetrahydrocannabinol exposure induces a sensitization of dopamine D₂/₃ receptors in the mesoaccumbens and nigrostriatal systemsNathalie Ginovart, Benjamin B Tournier, Marcelle Moulin-Sallanon, et al.Frontiers in Oncology|December 31, 2021
Biomarkers to Evaluate Androgen Deprivation Therapy for Prostate Cancer and Risk of Alzheimer's Disease and Neurodegeneration: Old Drugs, New ConcernsVérane Achard, Kelly Ceyzériat, Benjamin B Tournier, et al.Plos One|September 6, 2018
Dynamic image denoising for voxel-wise quantification with Statistical Parametric Mapping in molecular neuroimagingStergios Tsartsalis, Benjamin B Tournier, Christophe E Graf, et al.Hypertension (Dallas, Tex. : 1979)|December 18, 1998
Decreased flow-induced dilation and increased production of cGMP in spontaneously hypertensive ratsH Y Qiu, D Henrion, J Benessiano, et al.Journal of Alzheimer'S Disease : JAD|February 11, 2020
Low-Dose Radiation Therapy: A New Treatment Strategy for Alzheimer's Disease?Kelly Ceyzériat, Benjamin B Tournier, Philippe Millet, et al.Molecular Imaging|September 25, 2014
A modified simplified reference tissue model for the quantification of dopamine D2/3 receptors with [18F]fallypride imagesStergios Tsartsalis, Marcelle Moulin-Sallanon, Noé Dumas, et al.Current Alzheimer Research|March 5, 2020
Learning from the Past: A Review of Clinical Trials Targeting Amyloid, Tau and Neuroinflammation in Alzheimer's DiseaseKelly Ceyzériat, Thomas Zilli, Philippe Millet, et al.Pageof 8